# Supernus Pharmaceuticals to Participate in March Investor Conferences
Canonical URL: https://biopharmsignal.com/news/SUPN/supernus-pharmaceuticals-to-participate-in-march-investor-conferences
Ticker: SUPN
Company: Supernus
Source: Supernus
Published: 2026-02-23 23:15 EST
Original Source URL: https://ir.supernus.com
## Summary

ROCKVILLE, Md., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that management will participate in the

## Article Body
ROCKVILLE, Md., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that management will participate in the
## Recent Company News
- 2026-07-22 21:05 EST — [Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026](https://biopharmsignal.com/news/SUPN/supernus-pharmaceuticals-to-announce-second-quarter-2026-financial-results-and-h-58b4f63d) — Source: Supernus
- 2026-07-14 12:30 EST — [Supernus Celebrates Five-Year Anniversary of Qelbree® FDA Approval, Continuing to Deliver on Real-World Experience in ADHD](https://biopharmsignal.com/news/SUPN/supernus-celebrates-five-year-anniversary-of-qelbree-fda-approval-continuing-to--ca53fc4f) — Source: Supernus
- 2026-05-27 20:30 EST — [Supernus Pharmaceuticals to Participate in June Investor Conferences](https://biopharmsignal.com/news/SUPN/supernus-pharmaceuticals-to-participate-in-june-investor-conferences) — Source: Supernus
- 2026-05-06 21:00 EST — [Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference](https://biopharmsignal.com/news/SUPN/supernus-pharmaceuticals-to-participate-in-the-bank-of-america-2026-health-care-conference) — Source: Supernus
- 2026-05-05 20:05 EST — [Supernus Announces First Quarter 2026 Financial Results](https://biopharmsignal.com/news/SUPN/supernus-announces-first-quarter-2026-financial-results) — Source: Supernus
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)